2 results
Approved WMOCompleted
Primary objective: To demonstrate a clinically significant improvement in morning FEV1 in moderate to severe allergic asthmatics inadequately controlled by ICS therapy treated with QAW039 for 12 weeks compared to placebo.Secondary objectives:…
Approved WMOWill not start
Prove by means of RSA, that HA coating has an advangtage in stability of the uncemented SL-PLUS femoral component in primary total hip arthroplasty.